George Conley, MD
Otolaryngology · Phoenix, AZNPI 1457330250
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,659 of the $2,523 with a category attached, or 65.7%. Integra Lifesciences Corporation accounts for 71.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $2,240 and has fallen 97.5% since, to $56 in 2025.
Across 22 payments — averaging $114.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- Cochlear Americas$319
- Inspire Medical Systems, Inc.$277
- GSK$54
- Sanofi$25
- Optinose US, Inc.$24
- plus $16 from 1 others
What the payments were for
- Travel & lodging$1,65966%
- Food & beverage$86434%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 8 | $1,810 |
| Cochlear Americas | 3 | $319 |
| Inspire Medical Systems, Inc. | 6 | $277 |
| GSK | 2 | $54 |
| Sanofi | 1 | $25 |
| Optinose US, Inc. | 1 | $24 |
| Aerin Medical Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,523 in reported general payments places this provider in the 65th percentile of 150 otolaryngology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 23 | $2,585 |
| Fluocinolone Acetonide Oil | 26 | $1,264 |
| Ofloxacin | 31 | $824 |
| Prednisone | 14 | $65 |
| Oxycodone Hcl | 15 | $58 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Phoenix
- Peter KaiserPhoenix$114K
- Farhan TaghizadehPhoenix$46K
- Shawn StevensPhoenix$33K
- Richard PearlsteinPhoenix$10K
- Devyani LalPhoenix$8K
- Christian PaquetPhoenix$8K
- Alyson KaplanPhoenix$6K
- Manikandan SugumaranPhoenix$6K
- Robert BridgePhoenix$6K
- Jeffrey TaffetPhoenix$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.